Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Burden of Breast Cancer and Attributable Risk Factors in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019 Publisher



Azadnajafabad S1 ; Moghaddam SS1, 2 ; Mohammadi E1, 3 ; Rezaei N1, 4 ; Rashidi MM1 ; Rezaei N1, 4 ; Mokdad AH5, 6 ; Naghavi M5, 6 ; Murray CJL5, 6 ; Larijani B4 ; Farzadfar F1, 4 ; Abbasikangevari M1 ; Abbasikangevari Z1, 7 ; Abbastabar H8 Show All Authors
Authors
  1. Azadnajafabad S1
  2. Moghaddam SS1, 2
  3. Mohammadi E1, 3
  4. Rezaei N1, 4
  5. Rashidi MM1
  6. Rezaei N1, 4
  7. Mokdad AH5, 6
  8. Naghavi M5, 6
  9. Murray CJL5, 6
  10. Larijani B4
  11. Farzadfar F1, 4
  12. Abbasikangevari M1
  13. Abbasikangevari Z1, 7
  14. Abbastabar H8
  15. Abidi H9
  16. Abolhassani H10, 11
  17. Abubaker Ali H12
  18. Abugharbieh E13
  19. Acuna JM14, 15
  20. Afrashteh S16, 17
  21. Afzal MS18
  22. Ahmad S19
  23. Ahmadi A20, 21
  24. Ahmadi S22
  25. Ahmed H23
  26. Ahmed LA24
  27. Rashid TA25
  28. Ajami M26, 27
  29. Akbarzadehkhiavi M28
  30. Hamad HA29, 30
  31. Alhanawi MK31, 32
  32. Ali BA33, 34
  33. Alimohamadi Y35
  34. Alipour S36
  35. Aljunid SM37, 38
  36. Almustanyir S39, 40
  37. Alraddadi RM41
  38. Alvand S42
  39. Arabloo J43
  40. Arabzozani M44
  41. Aryannejad A1, 45
  42. Ashraf T46
  43. Athari SS47
  44. Jafari AA48
  45. Bagheri N49
  46. Bagherieh S50
  47. Bahadory S51, 52
  48. Behnammoghadam M53, 54
  49. Bhagavathula AS55
  50. Bohlouli S56
  51. Wolfram Bruck WM57
  52. Darwesh AM58
  53. Dianatinasab M17, 59
  54. Dorostkar F60
  55. Eini E61
  56. Elbarazi I24
  57. Elhadi M62
  58. Sayed IE63
  59. Zaki MES64
  60. Eskandarieh S65
  61. Fadhil I66
  62. Farahmand F67
  63. Faris PS68, 69
  64. Galehdar N70
  65. Ghafourifard M71
  66. Ghamari SH1, 7
  67. Ghamari A1
  68. Ghashghaee A72
  69. Gholamalizadeh M73
  70. Gohari K1, 74
  71. Goleij P75
  72. Golitaleb M76
  73. Gubari MIM77
  74. Hafezinejad N4, 78
  75. Halwani R13, 79
  76. Hamadeh RR80
  77. Hamidi S81
  78. Hanif A82
  79. Haque S83
  80. Hassanipour S84, 85
  81. Hayat K86, 87
  82. Heidari M88
  83. Heidarymeybodi Z89
  84. Hosseini MS90
  85. Hosseinzadeh M91, 92
  86. Hsairi M93
  87. Jamshidi E94, 95
  88. Mamaghani AJ96, 97
  89. Javaheri T98
  90. Kabir A99
  91. Kalankesh LR100
  92. Keikavoosiarani L101
  93. Khader YS102
  94. Khan EA103
  95. Khan G104
  96. Khayamzadeh M105, 106
  97. Kiani B107
  98. Koohestani HR108
  99. Lee SW109
  100. Letafatnezhad M110
  101. Livani S111
  102. Madadizadeh F112
  103. Mafi AR113
  104. Mahjoub S114, 115
  105. Mahmoodpoor A116
  106. Mahmoudimanesh M117
  107. Malekpour MR1
  108. Malik AA82, 118
  109. Mansourghanaei F84, 85
  110. Mansournia MA119
  111. Masoumi SZ120
  112. Nasab EM121
  113. Mirmoeeni S48
  114. Mohammad Y122
  115. Mohammad KA68
  116. Mohammadi M123
  117. Mohammed A124
  118. Momtazmanesh S1, 4
  119. Moradi A125
  120. Moraga P126
  121. Mosapour A115, 127
  122. Naqvi AA128
  123. Natto ZS129, 130
  124. Nejadghaderi SA1, 131
  125. Nojomi M132, 133
  126. Noori M134
  127. Okatialiabad H135
  128. Pakzad R136
  129. Toroudi HP137, 138
  130. Piracha ZZ139
  131. Pourtaheri N140
  132. Rabiee N141, 142
  133. Rafiei A143, 144
  134. Rahim F145
  135. Rahimidehgolan S146
  136. Rahmani AM147
  137. Rahmanian V148
  138. Rashidi M149
  139. Rashidi A150
  140. Rawassizadeh R151
  141. Razeghinia MS152, 153
  142. Rezaei N1, 4
  143. Sabour S21
  144. Saddik B155
  145. Saeed U139, 156
  146. Sahebazzamani M157, 158
  147. Sahebkar A159, 160
  148. Samy AM161
  149. Nadeem Saqib MA162, 163
  150. Sathian B29, 164
  151. Shafiee SM165
  152. Shahabi S166
  153. Shahrakisanavi F135
  154. Shaikh MA167
  155. Sheidaei A1, 119
  156. Alisheikhi R168
  157. Shirkoohi R169, 170
  158. Shobeiri P1, 4
  159. Soltanizangbar MS171
  160. Tabibian E172
  161. Taheri M173, 174
  162. Soodejani MT175
  163. Temsah MH176
  164. Tiyuri A177, 178
  165. Ullah I18
  166. Ullah S179, 180
  167. Tahbaz SV181, 182
  168. Valizadeh R183
  169. Vo B184
  170. Waheed Y185
  171. Yahyazadeh Jabbari SH181
  172. Yazdanpanah F186, 187
  173. Yuce D188
  174. Zaki N189
  175. Zare I190
  176. Zoladl M191

Source: Frontiers in Oncology Published:2023


Abstract

Background: Breast cancer (BC) is the most common cancer in women globally. The North Africa and Middle East (NAME) region is coping hard with the burden of BC. We aimed to present the latest epidemiology of BC and its risk factors in this region. Methods: We retrieved the data on BC burden and risk factors from the Global Burden of Disease Study 2019 to describe BC status in the 21 countries of the NAME region from 1990 to 2019. We explored BC incidence, prevalence, deaths, disability-adjusted life years (DALYs), and attributable burden to seven risk factors of female BC, namely, alcohol use, diet high in red meat, low physical activity, smoking, secondhand smoke, high body mass index, and high fasting plasma glucose. Decomposition analysis on BC incidence trend was done to find out the contributing factors to this cancer’s growth. Results: In 2019, there were 835,576 (95% uncertainty interval: 741,968 to 944,851) female and 10,938 (9,030 to 13,256) male prevalent cases of BC in the NAME region. This number leads to 35,405 (30,676 to 40,571) deaths among female patients and 809 (654 to 1,002) deaths in male patients this year. BC was responsible for 1,222,835 (1,053,073 to 1,411,009) DALYs among female patients in 2019, with a greater proportion (94.9%) of burden in years of life lost (YLLs). The major contributor to female BC incidence increase in the past three decades was found to be increase in age-specific incidence rates of BC (227.5%), compared to population growth (73.8%) and aging (81.8%). The behavioral risk factors were responsible for majority of attributable female BC burden (DALYs: 106,026 [66,614 to 144,247]). High fasting plasma glucose was found to be the risk factor with the largest effect (DALYs: 84,912 [17,377 to 192,838]) on female BC burden. Conclusion: The increasing incidence and burden of BC in the NAME region is remarkable, especially when considering limited resources in the developing countries of this region. Proper policies like expanding screening programs and careful resource management are needed to effectively manage BC burden. Copyright © 2023 Azadnajafabad, Saeedi Moghaddam, Mohammadi, Rezaei, Rashidi, Rezaei, Mokdad, Naghavi, Murray, Larijani, Farzadfar and GBD 2019 NAME Breast Cancer Collaborators.
Other Related Docs